Development of an Improved Guanidine-Based Rac1 Inhibitor with in vivo Activity against Non-Small Cell Lung Cancer.
Ciarlantini MS, Barquero A, Bayo J, Wetzler D, Dodes Traian MM, Bucci HA, Fiore EJ, Gandolfi Donadío L, Defelipe L, Turjanski A, Ramírez JA, Mazzolini G, Comin MJ.
Ciarlantini MS, et al.
ChemMedChem. 2021 Mar 18;16(6):1011-1021. doi: 10.1002/cmdc.202000763. Epub 2021 Jan 25.
ChemMedChem. 2021.
PMID: 33284505